Such figures are difficult to interpret. Possibly, owing to the duration of the disease, patients of this type commonly die in their own homes.
When a fairly certain diagnosis of malignancy in a goitre can be made clinically, the prognosis is usually hopeless, but many enlarged thyroid glands are removed for a variety of reasons and the diagnosis of carcinoma only arrived at after a microscopical examination. Can a certain diagnosis of malignancy be made on the histological appearances? The answer is no. There are few more difficult problems which confront the pathologist than that of deciding when a nodular goitre has become malignant. Graham (I925) presented what he consid-ered to be the criteria of malignancy in the thyroid; since he insisted on invasion of blood vessels by tumour cells his standards were perhaps too stringent.
Age Incidence
Three-quarters of all these tumours occur between the ages of 40 and 70, the average age in the thyroid gland arising in a goitre which had been present for 17 years, the patient being 8o years old when first seen. The incision shows the site of removal of a large pre-tracheal mass which caused urgent dyspnoea.
men being 53 and in women 48 (Pemberton, 1939) . However, cancer of the thyroid is occasionally seen in children and young adults when it is usually of the papillary type. Reports from areas where goitre is endemic suggest a younger age incidence, Warren Cole (1945) reports an overall average age of 48 in patients treated in Chicago and presumably drawn from the surrounding state of Illinois.
Sex Incidence
In general about three females to every male are affected by this disease. The Registrar-General's figures quoted above give a ratio of 2.8 to I; in Joll's (I932) series for I9I8-30 it was 3 to I. Since enlargement of the thyroid gland is approximately nine times as common in women as in men, the latter show a greater proneness to malignant change.
Incidence of Carcinoma in Goitres
This depends chiefly on two factors. First, when the patient comes from a region in which goitre is endemic, the incidence is much higher (Crile, I949) (i) 
Pathology
The very fact that so many different classifications of cancer of the thyroid have been suggested in the past is good evidence that none is wholly satisfactory. rt will be found useful to divide these tumours in the first place into two main groups, papillary and non-papillary (Proc. Nat. Cancer Conf., 1949) .
Papillary cancer of the thyroid may occur at any age, but shows a decided tendency to occur in the young, possibly the youngest reported being in a child of four years. Typically it is a slow growing tumour and I know of a patient who had a cervical lymph node containing such a metastasis removed i6 years ago, who has had no further symptoms.
Crile reports a patient who harboured a similar tumour with little increase in size over 27 years.
Papillary carcinoma of the thyroid has a predilection for spreading by the lymphatics, especially in younger patients. This accounts for the previous concept that thyroid tissue could appea, laterally in the neck as a developmental abnormalityr the so-called lateral aberrant thyroid. Such tissue is the result of spread of a highly differentiated papillary tumour into a cervical lymph node, (Lahey, I946; Crile, I947) . The primary growth may be so small that it is only discovered after cutting serial sections of the thyroid lobe on the affected side; the title of ' occult carcinoma of the thyroid' has been suggested for such tumours (Wozencraft, I948).
The non-papillary tumours can be subdivided into groups according to their histological appearance (Wegelin, I926) or according to their clinical behaviour (Lahey, I940) .
Histologically they appear as: (a) Adenocarcinomas with colloid formation; tumours which reproduce fairly faithfully the structure of the parent gland.
(b) Adenocarcinomas without colloid formation; less differentiated than the foregoing.
(c) Carcinoma simplex; solid tumours whose cells show varying degrees of differentiation. In their most anaplastic form the histological picture of these tumours may be indistinguishable from sarcoma, though whether sarcoma of the thyroid ever occurs is of academic interest only.
One further tumour requires mention because of its distinctive appearance. This is the so-called Hiurthle cell type, which is comprised of eosinophilic cells surrounding small alveoli. Willis (I948) has pointed out that it is trebly unfortunate that such tumours should be classified separately and dignified with the eponym Hiirthle. Hurthle was not the first to describe-these cells, since Baker did so 17 years earlier. Hiirthle thought that these large pink-staining cells were interfollicular, but interfollicular cells probably do not exist as Rienhoff's (1929) wax reconstructions show. Finally these cells are probably only a variant of alveolar cells and can be found in many other conditions, though not in such large numbers (Lennox, 1948) .
Clinically the non-papillary thyroid cancers can be conveniently divided into those which are well differentiated and show some degree of thyroid function and those which are non-functioning.
The last 28 consecutive cases of thyroid cancer treated at Hammersmith Hospital have included five proved cases of papillary adenocarcinoma. The remainder have shown every type of histological picture from the alveolar type with colloid formation to the most undifferentiated variety which, on occasion, was labelled sarcoma.
Surgery
The most important form of treatment for almost every case of carcinoma of the thyroid is a surgical operation, but the form which the operation takes must be decided by the variety and extent of the tumour. Once again it is convenient to consider separately two main groups; the papillary and the non-papillary carcinomas.
Papillary carcinoma of the thyroid is essentially slow growing and occurs in the younger age groups. The diagnosis may be made on the operating table when an enlarged lymph node removed from the neck is found to contain metastatic thyroid tissue. When the disease is confined to one side of the neck the lobe of the thyroid gland on that side should be removed in its entirety, no matter how normal it appears, since a primary growth may be only a millimetre in diameter. If the isthmus is involved then the resection will haive to include a generous portion of the contralateral thyroid lobe. A decision has then to be made on how radical should be the removal of the lymphatic drainage on the affected side. Here it has to be remembered that the tnmour is usually a slow growing one, the patient often young and very often a girl. Bearing these facts in mind it is not justifiable to carry out a block dissection of the neck, involving as it does removal of the sternomastoid muscle and probably the internal jugular vein, although many surgeons have proposed it (Metzger, 1948 There are a, few patients who have slowly growing cancers and who when first seen present serious signs of obstruction to trachea and great vessels. Often these people are only capable of breathing whilst sitting bolt upright and they show great enlargement of their neck veins; surgery for these can only be a palliative, but it is well worth while. They are taken to the operating theatre and, if possible, anaesthesia is induced with the patient sitting up, and a tracheal tube passed. As much of the tumour as possible is then cut away, and if necessary a tracheotomy tube is inserted. The latter is by no means always required. The subsequent treatment of these patients is mainly bv radiotherapy.
Finally there is an anaplastic type of thyroid carcinoma often occurring in middle aged males, which can only be described as fulminating. For these radiotherapy is ideal. Surgical treatment is only indicated in so far as a tracheotomy may be required to spare the patient the agony of death by strangulation. Even after intensive radiotherapy these tumours may fungate through the tracheotomy opening within the space of a few days. Fortunately, however, this type of tumour is usually radiosensitive. X-ray Therapy For many years X-ray therapy has been used extensively for the treatment of carcinoma of the thyroid, and an outstanding contribution to this subject was made by Graham and McWhirter (1947) In the body the radioactive element I131 behaves in precisely the same manner as the stable form I127 and is concentrated in the thyroid gland. It is of importance that radioiodine can be prepared in the atomic pile free from stable iodine (i.e., carrierfree) because then, when a dose of radioiodine is given to a patient, it will be known that the iodine taken up by the gland is the radioactive isotope.
The value of radioiodine in cancer of the'thyroid is twofold. It may be used as an aid in diagnosis and, on rare occasions, for the treatment of thyroid metastases.
Radioiodine in Diagnosis
A substantial number of patients with thyroid cancer have now been investigated with radioiodine and the number showing uptake of radioiodine by the tumour cells is small. Fitzgerald (1949) gave ioo patients radioiodine and 46 showed some concentration in the tumour cells, but in none was it equal to the concentration in the uninvolved thyroid. Because of these two observations it will be seen that if a patient is given a tracer dose and a directional Geiger-Miller counter is used to scan the activity in the neck, should a nodule show markedly less activity than the surrounding thyroid tissue it raises the pos- thyroid gland, then the best stimulus to the tumour cells to take on thyroid activity will be complete removal of the gland, since by this means there will be lack of thyroxine in the blood stream. This wlIl lead to overactivity of the anterior pituitary and the production of thyroid stimulating hormone (TSH), the latter inducing the tumour cells to manufacture thyroxine if they are in fact capable of so doing. The importance of this mechanism was first pointed out by Rawson et al. (I948) and is illustrated in Diag. 4.
The practice of giving patients with carcinoma of the thyroid a tracer dose of radioiodine in order to see if the tumour or its metastases take up significant amounts is therefore not of much value. It gives no indication of how the metastases will behave after any normal thyroid tissue has been removed. In order to use radioiodine to irradiate malignant thyroid tissue it is necessary first to destroy any normal thyroid cells. Clearly the best way of removing thyroid tissue is by a surgical operation since this serves three purposes: It reveals the extent of the primary growth, provides the pathologist with adequate material for histological examination and permits an attempt to be made to eradicate the tumour. In frail patients who are unlikely to stand the strain of such' an operation it is justifiable to give a dose of radioiodine calculated to destroy all the normal functioning thyroid tissue. This will usually be of the order of 40 to 8o millicuries, and overdosage is permissible under the circumstances.
The proportion of patients who benefit under this plan of treatment is small. During the last 12 months at the Christie Hospital, Manchester (Warrington, 1950) , 2I patients were seen with cancer of the thyroid and 8 took up a significant amount of radioiodine. It is possible that patients' lives are prolonged under such circumstances and it is a great advantage that the treatment consists merely of drinking a glass of water containing 1131 with practically ro toxic effects.
The treatment of these patients can be carried yet a stage further by various methods for stimulating the metastases to take on increased thyroid function after total thyroidectomy. Two different lines of attack have so far produced satisfactory results. The first, and perhaps most obvious, is -the injection of thyroid stimulating hormone .(TSH) for a number of days before giving the radioiodine, following which a significantly greater uptake has been reported (Seidlin, I948) . The second method consists of giving really large doses (up 'to 2 gm. per day), of methyl thiouracil for a month or longer, this appears to produce changes in the metastases comparable-with those that occur in the nonnal thyroid gland, i.e. disappearance of colloid, increase of acinar cell height, increased vascularity and overall size of tumour. The thiouracil is then stopped for two days, the block to thyroxine formation is thus released and on administering the radioiodine a substantially increased uptake is recorded (Trunnel, et al., I949) .
Ever since Von Eiselsberg (I894) first described a patient with hyperfunctioning thyroid metastases, such cases have always held a fascination for the thyroidologist. The introduction of radioactive iodine has made them almost ideal patients for isotope therapy and the first example of a happy result from such treatment is the patient reported by Seidlin (1946) . Unfortunately this type of thyroid carcinoma is excessively rare.
The value of radioiodine in the treatment of thyroid cancer can be summarized as follows:
i. The principal use of radioiodine is in the treatment of metastases.
2. Only those metastases which will take up, or can be made to take up, radioiodine can be treated.
3. Less than 50 per cent. of all thyroid tumours take up radioiodine.
4. No tumour concentrates radioiodine as effectively as normal thyroid tissue.
5. The most important preliminary to this form of treatment is the removal by surgery or the destruction by radioiodine of all normal functioning thyroid cells, in order that the metastases can be stimulated to take on thyroid function.
6. The radioiodine uptake of the metastases can be further stimulated by the prolonged administration of methyl thiouracil in large dosage, which is then stopped at least 48 hours before giving the radioiodine. TAYLOR: Carcinoma of the Thyroid rats and mice over a long period leads to tumour formation (Money, 1946) . The first changes in the thyroid are those of increased cell height, disappearance of colloid and greater vascularity. Then the epithelium throws out papillary processes into the acini and hypertrophy of these papillae eventually progresses to adenoma formation. Occasionally one of these experimentally produced nodular goitres develops a true carcinoma (Purves and Griesbach, I947), but it must be remembered that the thiouracil has to be administered to the animal for a time which, when translated into terms of man, would represent a considerable part of his life's span.
Such spontaneous cancers in thiouracil goitres in animals are rare. If, however, a carcinogen is given to the animals in addition to the thiouracil, thyroid cancer may be produced more readily. Bielschowsky (1945) produced such tumours by giving rats allyl-thiourea and 2-acetyl-aminofluorene. It has also been shown that radioiodine when administered to mtce treated over a long period with thiouracil can produce malignant tumours (Doniach, 1950) . This is a most disturbing observation since both these, thiouracil and radioiodine, are in everyday use for the treatment of thyrotoxicosis. Fortunately it appears that these substances have to be used in considerably larger doses and for longer periods than is normally the case in man, but clearly it will be necessary to have much more information on this subject. It is particularly important to know what will be the long term results of giving radioiodine in therapeutic doses to patients with toxic goitres. Until statistics are available covering a period of 20 years it may well be inadvisable to give radioiodine for the treatment of Graves' disease in young people unless there were very good reasons for it, e.g. severe heart disease or previous multiple operations on the neck.
Summary Prophylaxis
The prevention of nodular goitre will inevitably decrease the incidence of cancer of the thyroid, since often this develops in a longstanding goitre. The introduction in Britain this year of a small quantity of iodine into domestic salt as recommended by the Medical Research Council will be a help in this direction. Diagnosis A careful case history and a thorough examination, especially of the neck, offer the best chance of providing the diagnosis. Solitary nodules in nontoxic goitres, especially in younger patients, should always raise the strongest suspicion of malignancy.
Radioiodine may be of some assistance, since malignant tissue will pick up little if any in contrast to normal thyroid tissue. Thus if, after a tracer dose, the neck is carefully scanned with a directional Geiger-Muller counter and a thyroid nodule is found to have no activity, the possibility of malignancy might be entertained.
The histological examination of tissue removed from the thyroid gland will always be necessary for a firm diagnosis. Even then the pathological picture may still give rise to varying interpretations and it may be many years before the behaviour of the tumour makes the correct diagnosis possible. Treatment
The first and foremost form of treatment in carcinoma of the thyroid, whether it be overt or onlv suspected is, with rare exceptions, surgical excisiqn. There are three good reasons for this. First, it may prove possible to excise the tumour completely and thus offer the patient the best chance of a cure. Secondly, tissue is removed which can be examined by a pathologist so that an accurate diagnosis is obtained. Thirdly, should the tumour be-a well-differentiated type of adenocarcinoma with metastases, the removal of the parent gland may result in the metastases taking on thyroid function and thus make them capable of treatment with radioiodine.
The operation performed will depend on the type of tumour encountered. A solitary nodule is best removed with that lobe of the gland in which it is found. A papillary carcinoma in a younger patient is best dealt with by hemi-thyroidectomy and multiple non-mutilFting incisions for excising the affected lymph nodes as and when they become involved. If the lymph nodes are widelv involved a block dissection of that side of the neck completes the operation. Adenocarcinoma is treated, where possible, by total thyroidectomy and subsequent block dissections of the cervical lymph nodes when they are found clinically to be in- Radioiodine is used 'in those patients whose metastases take on function'after total thyroidec--tomy. It may prolong life and greatly increase the patient's sense of well be'ing. Probably not more than 15 per cent. of all patients with carcinoma of the thyroid gland seen at the present time are capable of being treaLed in this manner.
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